MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Clinical trials for MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION explained in plain language.
Never miss a new study
Get alerted when new MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION trials appear
Sign up with your email to follow new studies for MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a common sedative shield your brain after bypass surgery?
Disease control Recruiting nowThis large trial tests whether the sedative dexmedetomidine can prevent long-term memory and thinking problems that often follow heart surgery. Researchers will give the drug to 2,400 adults aged 60 and older during and after their operation, then track their cognitive function f…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New hope for Treatment-Resistant depression: Fast-Acting drug trial launches
Symptom relief Recruiting nowThis study tests whether a new drug called HNK can quickly improve symptoms in people with major depression that hasn't responded to other treatments. About 50 adults aged 18 to 70 will receive four infusions of HNK and four of a placebo over several weeks, with their depression …
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New injection could smooth away neck bands
Symptom relief Recruiting nowThis phase 3 trial tests whether NT 201 (a botulinum toxin injection) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) in adults. About 300 participants in Europe will receive either NT 201 or a placebo injection. The study measures improvem…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
NIH launches study to uncover clues in mood disorder treatments
Knowledge-focused Recruiting nowThis study follows 500 adults already receiving care for depression, bipolar disorder, or suicide risk at the NIH. Researchers will conduct weekly interviews and optional tests like blood draws and brain scans to track symptoms and treatment responses. The goal is to better under…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC